Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Language Processing | 5 | 2022 | 69 | 1.660 |
Why?
|
| Electronic Health Records | 4 | 2022 | 374 | 1.520 |
Why?
|
| Medication Adherence | 4 | 2017 | 335 | 1.520 |
Why?
|
| Hypoglycemic Agents | 4 | 2017 | 362 | 1.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2016 | 1085 | 1.180 |
Why?
|
| Algorithms | 5 | 2019 | 1196 | 1.090 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2012 | 88 | 0.780 |
Why?
|
| Vaccination | 2 | 2012 | 189 | 0.670 |
Why?
|
| Narration | 1 | 2019 | 29 | 0.660 |
Why?
|
| Medical Informatics Applications | 1 | 2019 | 22 | 0.660 |
Why?
|
| Social Isolation | 1 | 2019 | 40 | 0.650 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 498 | 0.640 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 298 | 0.600 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 49 | 0.600 |
Why?
|
| Accidental Falls | 1 | 2018 | 84 | 0.580 |
Why?
|
| Drug Substitution | 1 | 2017 | 19 | 0.570 |
Why?
|
| Hypolipidemic Agents | 1 | 2017 | 82 | 0.540 |
Why?
|
| Health Information Exchange | 2 | 2014 | 37 | 0.480 |
Why?
|
| Risk Assessment | 2 | 2018 | 2007 | 0.470 |
Why?
|
| Indiana | 5 | 2015 | 35 | 0.430 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 498 | 0.420 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 778 | 0.420 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2012 | 12 | 0.420 |
Why?
|
| Pharmacies | 1 | 2012 | 18 | 0.420 |
Why?
|
| Drug Costs | 1 | 2012 | 87 | 0.400 |
Why?
|
| Health Information Systems | 1 | 2011 | 18 | 0.390 |
Why?
|
| Prescription Drugs | 1 | 2012 | 71 | 0.390 |
Why?
|
| Immunization Schedule | 1 | 2009 | 25 | 0.350 |
Why?
|
| Neonatal Screening | 1 | 2009 | 43 | 0.330 |
Why?
|
| Medical Record Linkage | 1 | 2009 | 42 | 0.330 |
Why?
|
| Hospitalization | 1 | 2015 | 978 | 0.330 |
Why?
|
| Community Networks | 1 | 2009 | 96 | 0.320 |
Why?
|
| Internet | 1 | 2009 | 390 | 0.280 |
Why?
|
| Humans | 21 | 2022 | 68618 | 0.270 |
Why?
|
| Administration, Oral | 3 | 2015 | 411 | 0.250 |
Why?
|
| Medicaid | 2 | 2017 | 302 | 0.220 |
Why?
|
| Aged | 10 | 2019 | 14862 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2015 | 622 | 0.190 |
Why?
|
| Male | 12 | 2022 | 37321 | 0.180 |
Why?
|
| United States | 7 | 2017 | 7367 | 0.180 |
Why?
|
| Middle Aged | 10 | 2019 | 21147 | 0.170 |
Why?
|
| Personal Narratives as Topic | 1 | 2019 | 4 | 0.170 |
Why?
|
| Female | 12 | 2022 | 38074 | 0.170 |
Why?
|
| Support Vector Machine | 1 | 2019 | 15 | 0.160 |
Why?
|
| Brain Infarction | 1 | 2019 | 54 | 0.160 |
Why?
|
| Prevalence | 4 | 2016 | 1619 | 0.160 |
Why?
|
| Clinical Coding | 1 | 2018 | 21 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 237 | 0.140 |
Why?
|
| Retrospective Studies | 4 | 2019 | 7277 | 0.140 |
Why?
|
| Adult | 7 | 2022 | 21403 | 0.130 |
Why?
|
| Vocabulary, Controlled | 1 | 2015 | 13 | 0.130 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 67 | 0.120 |
Why?
|
| Testosterone | 1 | 2015 | 96 | 0.120 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2014 | 22 | 0.120 |
Why?
|
| Data Mining | 1 | 2015 | 45 | 0.120 |
Why?
|
| Retinal Detachment | 1 | 2014 | 14 | 0.120 |
Why?
|
| Health Surveys | 1 | 2016 | 489 | 0.120 |
Why?
|
| Body Weight | 1 | 2016 | 554 | 0.110 |
Why?
|
| Fluoroquinolones | 1 | 2014 | 49 | 0.110 |
Why?
|
| Health Services Research | 1 | 2015 | 209 | 0.110 |
Why?
|
| Albuminuria | 1 | 2014 | 171 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2014 | 157 | 0.110 |
Why?
|
| Weight Loss | 1 | 2016 | 319 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2015 | 384 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 239 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2012 | 46 | 0.100 |
Why?
|
| Software | 1 | 2015 | 418 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 161 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 843 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2016 | 621 | 0.100 |
Why?
|
| Survival Rate | 1 | 2015 | 1056 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2015 | 652 | 0.100 |
Why?
|
| Immunization | 1 | 2012 | 86 | 0.100 |
Why?
|
| Pain | 1 | 2015 | 472 | 0.100 |
Why?
|
| Polypharmacy | 1 | 2011 | 31 | 0.100 |
Why?
|
| Child | 3 | 2012 | 6405 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2014 | 329 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2011 | 71 | 0.090 |
Why?
|
| Data Collection | 1 | 2012 | 420 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2011 | 201 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 161 | 0.090 |
Why?
|
| Health Expenditures | 1 | 2012 | 170 | 0.090 |
Why?
|
| Vaccines | 1 | 2009 | 21 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 1753 | 0.090 |
Why?
|
| Young Adult | 4 | 2016 | 5717 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2009 | 106 | 0.080 |
Why?
|
| Lipids | 1 | 2010 | 298 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1054 | 0.080 |
Why?
|
| Directive Counseling | 1 | 2008 | 23 | 0.080 |
Why?
|
| Obesity | 1 | 2016 | 1076 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 212 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2012 | 3187 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 130 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1864 | 0.070 |
Why?
|
| Registries | 1 | 2009 | 733 | 0.070 |
Why?
|
| Infant | 1 | 2012 | 2891 | 0.060 |
Why?
|
| Heart Failure | 1 | 2014 | 1180 | 0.060 |
Why?
|
| Pediatrics | 1 | 2008 | 341 | 0.060 |
Why?
|
| Adolescent | 3 | 2015 | 8912 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 772 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2016 | 208 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2455 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2015 | 7029 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1553 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2016 | 867 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2008 | 1034 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2279 | 0.040 |
Why?
|
| Decision Trees | 1 | 2019 | 74 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 442 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 274 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 320 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 17 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 274 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1420 | 0.030 |
Why?
|
| Comorbidity | 1 | 2014 | 1426 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2223 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2077 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2176 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4848 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5731 | 0.020 |
Why?
|